All treatments
Treatment
zirconium Zr 89 crefmirlimab berdoxam clinical trials
2 indexed studies · 1 currently recruiting
- RecruitingPHASE2
CD8 PET Imaging in Metastatic Solid Tumours
This study looks at a new type of specialised scan for people with advanced cancer. It uses a small amount of a special substance called 89Zr-Df-crefmirlimab to create detailed pictures. This helps doctors see how well a new cancer treatment, called PD-1 antibody therapy, is working.
For: Locally Advanced Solid TumorNetherlands · Spain · United Kingdom - Active not recruitingPHASE2
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies
This study uses a special scan called a PET/CT with a medicine called zirconium Zr 89 crefmirlimab berdoxam. It’s for people with advanced melanoma, Merkel cell cancer, kidney cancer, or lung cancer. We want to see if this scan can help predict how well immunotherapy will work for their cancer.
For: Melanoma · Merkel Cell Carcinoma, Unspecified · Renal Cell CarcinomaUnited States · Australia · Belgium